Clinical trial

Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

NCT03540485

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-11-29

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-11-29Date precision: day

Registry last updated2026-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sclerosis, Multipleunresolved

Autoimmune Diseases of the Nervous Systemunresolved

Nervous System Diseasesunresolved

Autoimmune Diseasesunresolved

Interventions

MelatoninDRUG · verified · RxNorm: melatonin

PlaceboOTHER

Sponsors & collaborators

Fundación Pública Andaluza para la gestión de la Investigación en Sevillalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03540485 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.